Cardiac coronary artery bypass implant
Over 500k bypass surgeries are performed globally on the coronary arteries. Off-pump, minimally invasive surgery, and / or robot-assisted surgery hold promises for further reduction of complications and increasing efficiency.
A cardiac bypass technology that aims to further reduce complications and improve efficiency in the cardiac surgery field. The technology has been extensively tested pre-clinically, and is prepared for first in man studies.
Minimally invasive cardiac surgery;
Robot-assisted cardiac surgery.
The invention has been claimed in multiple patents.
UMC Utrecht Holding B.V., The Netherlands, is owner of the patent application and is offering the technology and associated intellectual property rights. Confidential information can be exchanged after signing a confidentiality agreement.
For more information please refer to
Jaap de Bruin, +31 6 11 31 34 34
Genoveva Heldens, +31 6 11 44 24 15